Levetiracetam Tablet
Product Images NDC 50090-7521

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Levetiracetam (NDC 50090-7521). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl500907521)

FDA Label Image

Structure Formula (Levetiracetam Tablets 1)

FDA Label Image

Figure 1 (Levetiracetam Tablets 2)

FDA Label Image

Figure2 (Levetiracetam Tablets 3)

This dataset provides information on the percentage of patients in a study comparing placebo with levetiracetam (2000 mg/day). It shows that 63% of patients were in the placebo group, while 35.2% were in the levetiracetam group. The numbers indicate there were 111 patients in the placebo group and 105 patients in the levetiracetam group.*

FDA Label Image

Figure3 (Levetiracetam Tablets 4)

FDA Label Image

Figure4 (Levetiracetam Tablets 5)

This text seems to be a table displaying percentages of different data points. It includes numbers for two groups, labeled "Placebo" and "Levetiracetam". The data may be related to a study or experiment involving these groups.*

FDA Label Image

Figure5 (Levetiracetam Tablets 6)

FDA Label Image

Figure6 (Levetiracetam Tablets 7)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.